Welcome to our dedicated page for SONOCO PRODUCTS CO SEC filings (Ticker: SON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SONOCO PRODUCTS CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SONOCO PRODUCTS CO's regulatory disclosures and financial reporting.
Sonoco Products Company director reports additional phantom stock units from dividend credits. A board member of Sonoco Products Company, identified as a director, filed a Form 4 disclosing the acquisition of 336.2 phantom stock units on 12/10/2025 at a price of $41.93 per unit under the company’s directors' deferred compensation plan. After this transaction, the reporting person beneficially owns 26,938.3 phantom stock units in direct form. Each phantom stock unit is the economic equivalent of one share of Sonoco common stock and will be settled in the future when the director retires or otherwise leaves board service, rather than being settled immediately.
Sonoco Products Company’s Chief Operating Officer, Rodger D. Fuller, reported routine equity-related activity. On 12/12/2025, he acquired 44.3 dividend equivalents on Restricted Stock Units, each economically equivalent to one share of Sonoco common stock. These dividend equivalent rights are credited quarterly and will be settled when he retires or otherwise leaves his role.
Following this transaction, Fuller beneficially owns 415 derivative securities tied to Sonoco common stock, held in direct ownership. The filing notes that the dividend equivalents were recorded at a conversion or exercise price of $0.0000, reflecting their nature as adjustments to existing restricted stock awards rather than open-market purchases.
Sonoco Products Company officer John M. Florence, General Counsel, Secretary and Vice President, reported automatic equity-related credits on 12/12/2025. The Form 4 shows the acquisition of 395.5 dividend equivalents on restricted stock units, each economically equal to one share of Sonoco common stock, bringing his total related derivative holdings to 3,955.4 units. He also acquired 531.9 phantom stock units, each also economically equal to one Sonoco common share, increasing his phantom stock balance to 42,615.9 units. The dividend equivalents and phantom units arise from quarterly dividend accruals and the officers' deferred compensation plan and will be settled upon his retirement or other termination of service.
Sonoco Products Company director reports dividend-based phantom stock units
Theresa J. Drew, a director of Sonoco Products Company, reported an acquisition of derivative securities in the form of phantom stock units on 12/10/2025. The filing shows she acquired 246 phantom stock units at a reference price of $41.93 per unit, bringing her total beneficial ownership in these derivative securities to 19,706.1 phantom stock units, held directly.
Each phantom stock unit is the economic equivalent of one share of Sonoco common stock and was credited under the company’s directors’ deferred compensation plan in connection with a quarterly dividend. These units will be settled in Sonoco common stock when Ms. Drew retires or otherwise leaves board service, aligning her compensation with the company’s long-term performance.
Sonoco Products Company director reports dividend-based phantom stock grant
A Sonoco Products Company director reported acquiring 825.8 phantom stock units on 12/10/2025 under the company’s directors’ deferred compensation plan. Each phantom stock unit is the economic equivalent of one share of Sonoco common stock, but will be settled in the future rather than immediately. The units were credited in connection with a quarterly dividend and priced at $41.93 per unit, bringing the director’s total beneficial holding in this deferred form to 66,162.6 phantom stock units, held directly. Settlement will occur upon the director’s retirement or other termination of service.
Sonoco Products Company President and CEO R. Howard Coker reported routine equity transactions in company stock. On 12/02/2025, he reported a transaction coded "G" involving 2,360 shares of common stock at a stated price of $0.0000, which indicates a non-cash transfer such as a gift. After this, he directly beneficially owned 495,545 shares of common stock, with an additional 17,873.7037 shares reported as indirectly owned through his spouse.
In a separate entry dated 12/12/2025, Coker acquired 888 dividend equivalents on restricted stock units, each economically equivalent to one share of Sonoco common stock. These derivative awards, shown with an underlying price of $41.93, brought his total derivative holdings related to these awards to 18,183.1 units. The filing notes that these quarterly dividend equivalent rights on restricted stock will be settled when he retires or otherwise terminates his service.
Sonoco Products Company officer Sean Cairns, President of Consumer Packaging EMEA/APAC, reported an equity-related transaction in a Form 4. On 12/12/2025, he acquired 76.4 dividend equivalents on restricted stock units, which are each economically equivalent to one share of Sonoco common stock. These rights reflect quarterly dividend equivalents on existing restricted stock and will be settled when he retires or otherwise leaves his role. Following this transaction, he beneficially owned 567.4 derivative securities tied to Sonoco common shares, held in direct ownership. The transaction was recorded at a derivative security price reference of $41.93 and a conversion or exercise price of $0.0000, underscoring that these are compensation-linked awards rather than open-market purchases.
Sonoco Products Company director reports phantom stock award
A director of Sonoco Products Company reported acquiring 109.7 phantom stock units on 12/10/2025. Each phantom stock unit is the economic equivalent of one share of Sonoco common stock, with this transaction reported at a reference price of $41.93 per share. After this award, the director beneficially owns a total of 8,792.3 phantom stock units, held as a direct interest.
The filing explains that these phantom stock units were acquired through the quarterly dividend feature of Sonoco’s directors’ deferred compensation plan and will be settled in common stock when the director retires or otherwise leaves board service. This is a routine equity-based compensation event rather than an open-market stock purchase or sale.
Sonoco Products (SON) filed a Form 4 showing officer Ernest D. Haynes reported derivative transactions on 11/03/2025. Two entries list Transaction Code F involving derivative awards tied to common stock.
The first covers Dividend equivalents on Restricted Stock Units with 8 underlying shares at $40.57, leaving 682.3 derivative securities beneficially owned. The second involves Restricted Stock Units with 60 underlying shares at $40.57, with 1,650 derivative securities beneficially owned after the transaction. Each RSU represents a contingent right to receive one share, and dividend equivalent rights settle upon retirement or termination, with RSUs vesting three years from grant.
Sonoco Products Company completed the sale of its ThermoSafe business to Arctic US Bidco, Inc. on November 3, 2025. The transaction totals up to $725,000,000, comprising $650,000,000 paid at closing on a cash‑free, debt‑free basis (subject to customary adjustments) and up to $75,000,000 of additional consideration tied to 2025 performance measures.
The company states that forward‑looking statements related to expected benefits, portfolio simplification, organizational streamlining, and capital investments are subject to risks and uncertainties, including the potential non‑achievement of performance measures for the additional consideration.